Genetic Circuit Therapeutics is a biotechnology company pioneering the next generation of cancer treatments using synthetic biology. We design and engineer gene circuits, which are programmable genetic systems that respond to cellular signals, to create highly selective and powerful therapies for aggressive cancers like skin cancer and small cell lung carcinoma.

Our core technology leverages synthetic gene networks that detect specific cancer markers and activate therapeutic responses only in cancerous cells. By combining molecular biology, genetic engineering, and systems design, our therapies aim to reduce off-target effects, lower toxicity, and improve outcomes for patients.

Founded by a team of young scientists and innovators, Genetic Circuit Therapeutics is currently in the research and development phase.

Our mission is to reprogram biology to treat cancer with greater precision, offering patients smarter and safer alternatives to traditional therapies.

GenCTX

This department focuses on conducting experiments and investigations to advance knowledge and achieve innovation.

GenCTX

Org chart

Teams

Research and Development

Offices

GenCTX

Org chart

Teams

Research and Development

Offices

Related companies